heat c virus hc infect world popup lead caps liver disease transplant pose serious grow worldwide public health problem partial address introduce new antivirus therapy howe treatment prevent infect particularly high risk popup vaccine predict use simply model signifies effect reduce rcid efficacy target highrisk intranet drug user could drama reduce like partial lp compose viral structure protein selfassembl noninfecti lack gene mater resemble native virus thu metres safe highly immunogen delivery platform abl induce potent adapt immune response current mani vlpbase vaccine enter clinic trial license lp b hb human papilloma hp use year core e include antigen heterogen chime also promise approach product differ express system bacteria yeast mammalian plant insect cell paper review immunogen anim well use product 